💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Immunomedics, Inc. (IMMU)
« Back to company indexIMMU Chatter Timeline
Stock Ticker for IMMU
Most Active Tweeters for IMMU
| User | Tweets |
|---|---|
| @biotechradar_eu | 4 |
| @askwarrenbuffet | 3 |
| @Jiantkwazi | 1 |
| @GripRoom | 1 |
| @UDowngrades | 1 |
Recent Tweets for IMMU
 |
@psuvafan007 @Biohazard3737 “Shares” are weak sauce. If you’re going to insider trade, at least go all in with $IMMU options. December 3rd 2021, 4:12pm |
 |
@biotechradar_eu Immunicum $IMMU Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study https://t.co/GRZjtFaXXd December 3rd 2021, 11:12am |
 |
@wuqicongnalilai $immu CFO told GF and 4 other people to load up 4 days prior to p3 data release then they all sold on the data rele… https://t.co/fdvayvPgJe December 3rd 2021, 7:12am |
 |
@SoundVU RT @saltadogato: $IMMU https://t.co/luW0gZ0P29 December 3rd 2021, 5:12am |
 |
@srqstockpicker RT @NedPagliarulo: Former $IMMU CFO charged by the SEC with insider trading around clinical trial results for company's breast cancer drug:… December 2nd 2021, 9:12pm |
 |
@bio_clouseau The former $IMMU CFO was fired from his CEO position @ Fore bio supposedly today https://t.co/CX0OibC1IK https://t.co/QpT0jVcdnM December 2nd 2021, 8:12pm |
 |
@UDowngrades $IMMU Immunomedics insider trading. https://t.co/rvK8I36H4l December 2nd 2021, 7:12pm |
 |
@Jiantkwazi @NedPagliarulo So this guy made multimillions off his $IMMU shares but felt the need to facilitate insider trading… https://t.co/KoYUr2EE4Y December 2nd 2021, 6:12pm |
 |
@cmac45068222 @adamfeuerstein $IMMU This is ??. Enforcement is all too rare in this sector where blatant and egregious insider tr… https://t.co/qQN7Oq2S6X December 2nd 2021, 6:12pm |
 |
@adar170 @Biohazard3737 to add insult to injury $IMMU https://t.co/hPujRSfu2q December 2nd 2021, 6:12pm |
 |
@saltadogato $IMMU https://t.co/luW0gZ0P29 December 2nd 2021, 5:12pm |
 |
@NedPagliarulo Former $IMMU CFO charged by the SEC with insider trading around clinical trial results for company's breast cancer… https://t.co/vaM6OYSaJv December 2nd 2021, 5:12pm |
 |
@askwarrenbuffet $NEW CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/mYnOMjN8up December 1st 2021, 1:12am |
|
@biotechradar_eu PCI Biotech $PCIB and Immunicum $IMMU Announce an Extension to Their Research Collaboration to Explore Novel Cancer… https://t.co/ncQSKSUm12 November 30th 2021, 7:11am |
|
@biotechradar_eu Immunicum $IMMU and PCI Biotech $PCIB Announce an Extension to Their Research Collaboration to Explore Novel Cancer… https://t.co/6sgAFcQAYd November 30th 2021, 7:11am |
 |
@bigpharmaguy @adar170 Not exactly an $IMMU situation, but if they had to confirm the data they would probably get removed from t… https://t.co/hjuXIOZXYe November 29th 2021, 9:11pm |
 |
@GripRoom @Tim40472238 I was thinking more like an $IMMU-sized deal. But yeah, they can pull the trigger on something smaller. November 29th 2021, 5:11pm |
|
@askwarrenbuffet $GTOR CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/RsrIrHIB2g November 23rd 2021, 4:11am |
|
@biotechradar_eu Immunicum $IMMU Publishes DCP-001 Mechanism of Action in the Journal Cells https://t.co/i9g7qRETTU November 22nd 2021, 10:11am |
|
@askwarrenbuffet $CRVS CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/PfgYWLjiPe November 21st 2021, 12:11am |
 |
@StevenReznik RT @murphycpr: I remember $IMMU chairman Aghazadeh saying literally "there are a lot of dumb people on wall street" back in April'20 after… November 16th 2021, 12:11pm |
 |
@murphycpr I remember $IMMU chairman Aghazadeh saying literally "there are a lot of dumb people on wall street" back in April'… https://t.co/unCzlnZiqc November 16th 2021, 4:11am |
|
@biotechradar_eu Immunicum $IMMU to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual Meeting https://t.co/sp12xAehHV November 9th 2021, 1:11pm |
 |
@2iqresearch ????#Insider, Ann-Charlotte (Lotta) Ferm, CFO @Immunicum, purchased $IMMU #stocks ??Nov 4-5 ?100,000 #shares ?$43… https://t.co/eI2J9Qt4hj November 8th 2021, 11:11am |
|
@askwarrenbuffet $CSX CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/4GeNYYEVOZ November 6th 2021, 9:11pm |
 |
@StockTipRobot Math clearly indicates that you should buy, sell, and hold Immunomedics $IMMU #WallStreetBets November 5th 2021, 7:11pm |
|
@biotechradar_eu Immunicum $IMMU to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH) https://t.co/ZJtJnpV5Wr November 4th 2021, 1:11pm |
|
@biotechradar_eu Immunicum $IMMU to Participate in Multiple Upcoming Industry and Investor Events in November https://t.co/E9lWBshe7t November 1st 2021, 7:11am |
|
@biotechradar_eu Immunicum $IMMU Interim Report July - Sep 2021 https://t.co/khlMJYc9Xs October 28th 2021, 6:10am |
|
@biotechradar_eu Immunicum $IMMU Appoints Lotta Ferm as Chief Financial Officer https://t.co/Gt4nLyaCGh October 26th 2021, 9:10am |
|
@TraderAlba $IMMU in free fall! Management and board do not seem to think this is a problem, despite the fact that next round… https://t.co/0iEsHxoHMA October 26th 2021, 8:10am |
 |
@Nutsforstocks @AcroInferno I owned $IMMU waaaaaayyyy back in 2013. Sold out of boredom and no knowledge as i had only bought bas… https://t.co/wYdFfrroJj October 21st 2021, 10:10pm |
 |
@SolomonDoug @JackDamn ?$GILD ahead of earnings - thoughts ?#Remdesivir should do well and other HIV businesses ?perhaps $IMMU will make impact. October 19th 2021, 12:10pm |
 |
@lblegend33 @KSzentessy Ya for every $immu there’s like 7-8 ones that got killed then get BO, unfortunately. October 11th 2021, 1:10pm |
 |
@theforceof4 See the similarities in stock price action between $AUPH and $IMMU (Which was bought out last Sept.) In the days le… https://t.co/GnNO9qiuMB October 9th 2021, 7:10pm |
|
@askwarrenbuffet $GVSI CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/IhQtsJCZJp October 7th 2021, 6:10pm |
|
@askwarrenbuffet $IMUX CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/VkAKue1T2J October 7th 2021, 4:10pm |
 |
@YuZhu4 RT @nolastevedore: Immigrant biotech leaders or those with new roots have shined recently Examples: $XLRN Habib Dable $IMMU Behzad Aghaza… October 4th 2021, 8:10pm |
 |
@nolastevedore Immigrant biotech leaders or those with new roots have shined recently Examples: $XLRN Habib Dable $IMMU Behzad A… https://t.co/dWyqsNaRyy October 4th 2021, 7:10pm |
 |
@Kevin_M_Biotech @Biohazard3737 Loved what they did with $immu September 30th 2021, 9:09pm |
|
@biotechradar_eu Immunicum $IMMU Announces Outcome of Subscription in Incentive Program LTI 2021/2024 https://t.co/jFX5J840QU September 29th 2021, 9:09am |
|
@askwarrenbuffet $SITS CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/cTd9K2Nb4D September 21st 2021, 1:09am |
 |
@Jman2881 @PharmTrader11 @NoNetflixNeeded Watch $immu $pbya real companies with revs otc ?’s September 20th 2021, 3:09am |
|
@askwarrenbuffet $JACK CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/utrxRuhBLh September 18th 2021, 11:09pm |
 |
@Pharming_Eric @DuaneReadeSanta $immu comparison is a bold one! September 17th 2021, 1:09am |
|
@SolomonDoug @JacobPlieth $gild and $immu looks interesting . September 16th 2021, 9:09am |
 |
@ResearchPool $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime i… https://t.co/ejGqGz1akD September 15th 2021, 12:09pm |
 |
@MikesChannelB RT @ResearchPool: $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime in Dece… September 14th 2021, 1:09pm |
|
@ResearchPool $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime i… https://t.co/YOzzijSbmH September 14th 2021, 1:09pm |
|
@ResearchPool $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime i… https://t.co/x16QNYpi1h September 14th 2021, 1:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?